Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving…
EyePoint Announces Proposed Public Offering of Common Stock
October 14, 2025 16:35 ET Â | Source: EyePoint Pharmaceuticals, Inc. WATERTOWN, Mass.,…
AV-Comparatives Nominated for Euregio Innovation Award at European Forum Alpbach 2025
Research uncovers serious vulnerabilities across multiple devices from two major smart home…
MG 3 receives four stars but suffers rare and serious seat failure in Euro NCAP crash test
LEUVEN, BELGIUM – For decades, MG’s catchy slogan was ‘Safety Fast’ as…
Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism
September 06, 2025 14:30 ET Â | Source: BridgeBio Pharma, Inc. - 80%…
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information…
Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger – CrazyBulk
New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle…
Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University of Tbingen
TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT)…
Minelab Unveils the GOLD MONSTER 2000: More Precision. More Depth. More Gold
ADELAIDE, Australia, July 1, 2025 /PRNewswire/ --Â Minelab is proud to announce the…
Lilavati Hospital Doctors Save Life of 78-Year-Old Woman with Serious Heart Disease
India's First Successful Transcatheter Transatrial Mitral Valve Replacement Surgery Performed at Lilavati…